UGT2B17 Polymorphism and Risk of Prostate Cancer: A Meta-Analysis

Figure 5

Sensitivity analysis of the summary odds ratio coefficients on the association between UGT2B17 polymorphism and prostate cancer risk. Results were computed by omitting each study in turn. Meta-analysis random-effect estimates (exponential form) were used. The two ends of the dotted lines represent the 95% CI.